Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies.
eNeurologicalSci
; 25: 100386, 2021 Dec.
Article
en En
| MEDLINE
| ID: mdl-34926841
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2021
Tipo del documento:
Article